Our Resources | Association for Accessible Medicines

In the News - AAM CEO Dan Leonard shares the industry's 2021 outlook with Chain Drug Review.

State Savings Map

Nov 25, 2020 | Erica Klinger

Health Care Savings, State by State

President Trump delivers remarks on delivering lower prescription drug prices

Nov 20, 2020 | Rachel Schwartz

AAM Statement on Trump’s Drug Pricing Ruling – Rebates and Most Favored Nation Model

American Flag in front of The White House in Washington D.C.

Nov 11, 2020 | Rachel Schwartz

AAM Statement on 2020 Election

Sandoz office

Nov 2, 2020 | Jewel Smith

Member Spotlight: Sandoz

Oct 29, 2020 | Erica Klinger

Top 10 Ways to Commemorate 10 Years of Biosimilars in the U.S.

Milan “Mike” Puskar

Oct 23, 2020 | Bob Billings

Thank you, Mike Puskar

Oct 20, 2020 | Sara Skubikowski

Adding up the Generic Savings for Americans with Cancer and Other Conditions

Biosimilars patient Jeni, 35, from Santa Clarita, CA

Oct 15, 2020 | Erica Klinger

Jeni Got Her Life Back, Thanks to a Biosimilar

Video

Oct 8, 2020 | Erica Klinger

Jeni's Story — Biosimilars Savings

Medicaid Generics Penalty

Oct 7, 2020 | Rachel Schwartz

AAM Statement on the Introduction of the Protecting Access to Affordable Medicines Act of 2020

Nitrosamines: An Industry Position Paper Based on Risk

Oct 6, 2020 | Erica Klinger

White Paper: Nitrosamines — An Industry Position Paper Based on Risk

Oct 5, 2020 | Ericka Nguyen

Generic Drugs and Biosimilars Secure Big Savings for U.S. Patients